Hundreds of Cystic Fibrosis Patients Become Eligible for ‘Life-Changing’ Therapy

Hundreds of cystic fibrosis patients become eligible for ‘life-changing’ therapy

Some people with the rarest forms of the disease have been unable to access the latest medicines.

expert reaction to NICE final draft guidance and NHS rollout of Alyftrek for children and adults with some forms of cystic fibrosis

Scientists comment on NICE final draft guidance and the NHS rollout of Alyftrek for Cystic Fibrosis.   David Ramsden, Cystic Fibrosis Trust Chief Executive, said: “Today’s announcements are a positive step in the journey to better treatments for more people with cystic fibrosis – a lifelong, life-limiting condition without a cure. It’s thanks to the incredible hard work and support of the CF community and everyone we work with that modulator dru…

NHS England » NHS to roll-out new ‘triple combination’ therapy for hundreds of children and adults with cystic fibrosis

Hundreds of children and adults with rare forms of cystic fibrosis in England will be able to access “life-changing” new ‘triple-combination’ therapy for the very first time, the NHS has announced. Vanzacaftor–tezacaftor–deutivacaftor (Alyftrek®), is the latest in a new generation of therapies to be made available on the NHS that help treat the underlying cause […]